Table of contents

Clinical and epidemiological research

• Extended report: Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group (18 May, 2009)

  M Rudwaleit, A G Jurik, K-G A Hermann, R Landewé, D van der Heijde, X Baraliakos, H Marzo-Ortega, M Østergaard, J Braun, J Sieper
• Extended report: Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease (17 April, 2008)

  G Hatemi, A Silman, D Bang, B Bodaghi, A M Chamberlain, A Gul, M H Houman, I Kötter, I Olivieri, C Salvarani, P P Sfikakis, A Siva, M R Stanford, N Stübiger, S Yurdakul, H Yazici
• Extended report: Progression of radiographic joint damage in rheumatoid arthritis: independence of erosions and joint space narrowing (28 October, 2008)

  J S Smolen, D M van der Heijde, D Aletaha, S Xu, J Han, D Baker, E W St Clair
• Extended report: Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study (17 October, 2008)

  E Harboe, A B Tjensvoll, S Maroni, L G Gøransson, O J Greve, M K Beyer, A Herigstad, J T Kvaløy, R Omdal
• Extended report: Influence of variants of Fcγ receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor α therapy in rheumatoid arthritis (17 October, 2008)

  J D Cañete, B Suárez, M V Hernández, R Sanmartí, I Rego, R Celis, C Moll, J A Pinto, F J Blanco, F Lozano
• Extended report: Occurrence and correlates of fatigue in psoriatic arthritis (17 October, 2008)

  J A Husted, B D Tom, C T Schentag, V T Farewell, D D Gladman
• Extended report: Sonographic-detected joint effusion compared with physical examination in the assessment of sacroiliac joints in spondyloarthritis (28 October, 2008)

  A Spadaro, A Iagnocco, G Baccano, F Ceccarelli, E Sabatini, G Valesini
• Extended report: Antimyeloperoxidase antibodies are a useful marker of disease activity in antineutrophil cytoplasmic antibody-associated vasculitides (28 October, 2008)

  B Terrier, D Saadoun, D Sène, P Ghillani, Z Amoura, G Deray, B Fautrel, J-C Piette, P Cacoub
• Extended report: Monitoring anti-TNFα treatment in rheumatoid arthritis: responsiveness of magnetic resonance imaging and ultrasonography of the dominant wrist joint compared with conventional measures of disease activity and structural damage (19 November, 2008)

  E A Haavardsholm, M Østergaard, H B Hammer, P Bøyesen, A Boonen, D van der Heijde, T K Kvien
• Extended report: Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study (19 November, 2008)

  N Nishimoto, N Miyasaka, K Yamamoto, S Kawai, T Takeuchi, J Azuma
• Extended report: Erosive progression is minimal, but erosion healing rare, in patients with rheumatoid arthritis treated with adalimumab. A 1 year investigator-initiated follow-up study using high-resolution computed tomography as the primary outcome measure (19 November, 2008)

  U Møller Døhn, A Boonen, M L Hetland, M S Hansen, L S Knudsen, A Hansen, O R Madsen, M Hasselquist, J M Møller, M Østergaard
• Extended report: The influence of socioeconomic status on the reporting of regional and widespread musculoskeletal pain: results from the 1958 British Birth Cohort Study (24 October, 2008)

  G J Macfarlane, G Norrie, K Atherton, C Power, G T Jones
• Extended report: Orthopaedic surgery in 255 patients with inflammatory arthropathies: longitudinal effects on pain, physical function and health-related quality of life (24 October, 2008)

  H Osnes-Ringen, T K Kvien, J E Henriksen, P Mowinckel, H Dagfinrud
• Extended report: Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis (14 June, 2009) Free

  R Torres, L Macdonald, S D Croll, J Reinhardt, A Dore, S Stevens, D M Hylton, J S Rudge, R Liu-Bryan, R A Terkeltaub, G D Yancopoulos, A J Murphy
• Concise report: Dual energy computed tomography in tophaceous gout (9 December, 2008)

  H K Choi, A M Al-Arfaj, A Eftekhari, P L Munk, K Shojania, G Reid, S Nicolaou
• Concise report: The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study (26 July, 2009)

  R Terkeltaub, J S Sundy, H R Schumacher, F Murphy, S Bookbinder, S Biedermann, R Wu, S Mellis, A Radin
• Concise report:

  A large multicentre analysis of CTGF −945 promoter polymorphism does not confirm association with systemic sclerosis susceptibility or phenotype

  (3 December, 2008)

  B Rueda, C Simeon, R Hesselstrand, A Herrick, J Worthington, N Ortego-Centeno, G Riemekasten, V Fonollosa, M C Vonk, F H J van den Hoogen, J Sanchez-Román, M A Aguirre-Zamorano, R García-Portales, A Pros, M T Camps, M A Gonzalez-Gay, M F Gonzalez-Escribano, M J Coenen, N Lambert, J L Nelson, T R D J Radstake, J Martin